カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のB型肝炎ワクチン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Mono Hepatitis B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO20820）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO20820
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：99
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のB型肝炎ワクチン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

B型肝炎ワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のB型肝炎ワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

B型肝炎ワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・酵母由来、CHO由来

用途別セグメントは次のように区分されます。
・子供、大人

世界のB型肝炎ワクチン市場の主要な市場プレーヤーは以下のとおりです。
・GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、B型肝炎ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なB型肝炎ワクチンメーカーの企業概要、2019年～2022年までのB型肝炎ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なB型肝炎ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別B型肝炎ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのB型肝炎ワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのB型肝炎ワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびB型肝炎ワクチンの産業チェーンを掲載しています。
・第13、14、15章では、B型肝炎ワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- B型肝炎ワクチンの概要
- 種類別分析（2017年vs2021年vs2028年）：酵母由来、CHO由来
- 用途別分析（2017年vs2021年vs2028年）：子供、大人
- 世界のB型肝炎ワクチン市場規模・予測
- 世界のB型肝炎ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- GSK、NCPC、Merck、Bio Kangtai、Dynavax、Hissen、KM Biologics、LG Life Sciences、Serum Institute
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：酵母由来、CHO由来
・用途別分析2017年-2028年：子供、大人
・B型肝炎ワクチンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・B型肝炎ワクチンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・B型肝炎ワクチンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・B型肝炎ワクチンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・B型肝炎ワクチンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Mono Hepatitis B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Mono Hepatitis B Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Children accounting for % of the Mono Hepatitis B Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Yeast Derived segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Mono Hepatitis B Vaccine include GSK, NCPC, Merck, Bio Kangtai, and Dynavax, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Mono Hepatitis B Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Yeast Derived
CHO Derived
Market segment by Application can be divided into
Children
Adult
The key market players for global Mono Hepatitis B Vaccine market are listed below:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Mono Hepatitis B Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Mono Hepatitis B Vaccine, with price, sales, revenue and global market share of Mono Hepatitis B Vaccine from 2019 to 2022.
Chapter 3, the Mono Hepatitis B Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Mono Hepatitis B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Mono Hepatitis B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Mono Hepatitis B Vaccine.
Chapter 13, 14, and 15, to describe Mono Hepatitis B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Mono Hepatitis B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Mono Hepatitis B Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Market Analysis by Application
1.3.1 Overview: Global Mono Hepatitis B Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Children
1.3.3 Adult
1.4 Global Mono Hepatitis B Vaccine Market Size & Forecast
1.4.1 Global Mono Hepatitis B Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Mono Hepatitis B Vaccine Sales in Volume (2017-2028)
1.4.3 Global Mono Hepatitis B Vaccine Price (2017-2028)
1.5 Global Mono Hepatitis B Vaccine Production Capacity Analysis
1.5.1 Global Mono Hepatitis B Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Mono Hepatitis B Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Mono Hepatitis B Vaccine Market Drivers
1.6.2 Mono Hepatitis B Vaccine Market Restraints
1.6.3 Mono Hepatitis B Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business
2.1.3 GSK Mono Hepatitis B Vaccine Product and Services
2.1.4 GSK Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 NCPC
2.2.1 NCPC Details
2.2.2 NCPC Major Business
2.2.3 NCPC Mono Hepatitis B Vaccine Product and Services
2.2.4 NCPC Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business
2.3.3 Merck Mono Hepatitis B Vaccine Product and Services
2.3.4 Merck Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Bio Kangtai
2.4.1 Bio Kangtai Details
2.4.2 Bio Kangtai Major Business
2.4.3 Bio Kangtai Mono Hepatitis B Vaccine Product and Services
2.4.4 Bio Kangtai Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Dynavax
2.5.1 Dynavax Details
2.5.2 Dynavax Major Business
2.5.3 Dynavax Mono Hepatitis B Vaccine Product and Services
2.5.4 Dynavax Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Hissen
2.6.1 Hissen Details
2.6.2 Hissen Major Business
2.6.3 Hissen Mono Hepatitis B Vaccine Product and Services
2.6.4 Hissen Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 KM Biologics
2.7.1 KM Biologics Details
2.7.2 KM Biologics Major Business
2.7.3 KM Biologics Mono Hepatitis B Vaccine Product and Services
2.7.4 KM Biologics Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 LG Life Sciences
2.8.1 LG Life Sciences Details
2.8.2 LG Life Sciences Major Business
2.8.3 LG Life Sciences Mono Hepatitis B Vaccine Product and Services
2.8.4 LG Life Sciences Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Serum Institute
2.9.1 Serum Institute Details
2.9.2 Serum Institute Major Business
2.9.3 Serum Institute Mono Hepatitis B Vaccine Product and Services
2.9.4 Serum Institute Mono Hepatitis B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Mono Hepatitis B Vaccine Breakdown Data by Manufacturer
3.1 Global Mono Hepatitis B Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Mono Hepatitis B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Mono Hepatitis B Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Mono Hepatitis B Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Mono Hepatitis B Vaccine Manufacturer Market Share in 2021
3.5 Global Mono Hepatitis B Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Mono Hepatitis B Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Mono Hepatitis B Vaccine Market Size by Region
4.1.1 Global Mono Hepatitis B Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Mono Hepatitis B Vaccine Revenue by Region (2017-2028)
4.2 North America Mono Hepatitis B Vaccine Revenue (2017-2028)
4.3 Europe Mono Hepatitis B Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Mono Hepatitis B Vaccine Revenue (2017-2028)
4.5 South America Mono Hepatitis B Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Mono Hepatitis B Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Mono Hepatitis B Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Mono Hepatitis B Vaccine Revenue by Type (2017-2028)
5.3 Global Mono Hepatitis B Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Mono Hepatitis B Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Mono Hepatitis B Vaccine Revenue by Application (2017-2028)
6.3 Global Mono Hepatitis B Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Mono Hepatitis B Vaccine Sales by Type (2017-2028)
7.2 North America Mono Hepatitis B Vaccine Sales by Application (2017-2028)
7.3 North America Mono Hepatitis B Vaccine Market Size by Country
7.3.1 North America Mono Hepatitis B Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Mono Hepatitis B Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Mono Hepatitis B Vaccine Sales by Type (2017-2028)
8.2 Europe Mono Hepatitis B Vaccine Sales by Application (2017-2028)
8.3 Europe Mono Hepatitis B Vaccine Market Size by Country
8.3.1 Europe Mono Hepatitis B Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Mono Hepatitis B Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Mono Hepatitis B Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Mono Hepatitis B Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Mono Hepatitis B Vaccine Market Size by Region
9.3.1 Asia-Pacific Mono Hepatitis B Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Mono Hepatitis B Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Mono Hepatitis B Vaccine Sales by Type (2017-2028)
10.2 South America Mono Hepatitis B Vaccine Sales by Application (2017-2028)
10.3 South America Mono Hepatitis B Vaccine Market Size by Country
10.3.1 South America Mono Hepatitis B Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Mono Hepatitis B Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Mono Hepatitis B Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Mono Hepatitis B Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Mono Hepatitis B Vaccine Market Size by Country
11.3.1 Middle East & Africa Mono Hepatitis B Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Mono Hepatitis B Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Mono Hepatitis B Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Mono Hepatitis B Vaccine
12.3 Mono Hepatitis B Vaccine Production Process
12.4 Mono Hepatitis B Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Mono Hepatitis B Vaccine Typical Distributors
13.3 Mono Hepatitis B Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Mono Hepatitis B Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Mono Hepatitis B Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GSK Basic Information, Manufacturing Base and Competitors
Table 4. GSK Major Business
Table 5. GSK Mono Hepatitis B Vaccine Product and Services
Table 6. GSK Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. NCPC Basic Information, Manufacturing Base and Competitors
Table 8. NCPC Major Business
Table 9. NCPC Mono Hepatitis B Vaccine Product and Services
Table 10. NCPC Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Merck Basic Information, Manufacturing Base and Competitors
Table 12. Merck Major Business
Table 13. Merck Mono Hepatitis B Vaccine Product and Services
Table 14. Merck Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Bio Kangtai Basic Information, Manufacturing Base and Competitors
Table 16. Bio Kangtai Major Business
Table 17. Bio Kangtai Mono Hepatitis B Vaccine Product and Services
Table 18. Bio Kangtai Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Dynavax Basic Information, Manufacturing Base and Competitors
Table 20. Dynavax Major Business
Table 21. Dynavax Mono Hepatitis B Vaccine Product and Services
Table 22. Dynavax Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Hissen Basic Information, Manufacturing Base and Competitors
Table 24. Hissen Major Business
Table 25. Hissen Mono Hepatitis B Vaccine Product and Services
Table 26. Hissen Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. KM Biologics Basic Information, Manufacturing Base and Competitors
Table 28. KM Biologics Major Business
Table 29. KM Biologics Mono Hepatitis B Vaccine Product and Services
Table 30. KM Biologics Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. LG Life Sciences Basic Information, Manufacturing Base and Competitors
Table 32. LG Life Sciences Major Business
Table 33. LG Life Sciences Mono Hepatitis B Vaccine Product and Services
Table 34. LG Life Sciences Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 36. Serum Institute Major Business
Table 37. Serum Institute Mono Hepatitis B Vaccine Product and Services
Table 38. Serum Institute Mono Hepatitis B Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Mono Hepatitis B Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Mono Hepatitis B Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Mono Hepatitis B Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Mono Hepatitis B Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Mono Hepatitis B Vaccine Production Site of Key Manufacturer
Table 44. Mono Hepatitis B Vaccine New Entrant and Capacity Expansion Plans
Table 45. Mono Hepatitis B Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Mono Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Global Mono Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Global Mono Hepatitis B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Mono Hepatitis B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Global Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Global Mono Hepatitis B Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Mono Hepatitis B Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Mono Hepatitis B Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Mono Hepatitis B Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Global Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. Global Mono Hepatitis B Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Mono Hepatitis B Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Mono Hepatitis B Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Mono Hepatitis B Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Mono Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. North America Mono Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. North America Mono Hepatitis B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Mono Hepatitis B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. North America Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. North America Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. North America Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Europe Mono Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 71. Europe Mono Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 72. Europe Mono Hepatitis B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Mono Hepatitis B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Europe Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Europe Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Mono Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Mono Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Mono Hepatitis B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Mono Hepatitis B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. South America Mono Hepatitis B Vaccine Sales by Country (2017-2022) & (K Units)
Table 87. South America Mono Hepatitis B Vaccine Sales by Country (2023-2028) & (K Units)
Table 88. South America Mono Hepatitis B Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Mono Hepatitis B Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. South America Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. South America Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. South America Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Mono Hepatitis B Vaccine Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Mono Hepatitis B Vaccine Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Mono Hepatitis B Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Mono Hepatitis B Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Mono Hepatitis B Vaccine Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Mono Hepatitis B Vaccine Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Mono Hepatitis B Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Mono Hepatitis B Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Mono Hepatitis B Vaccine Raw Material
Table 103. Key Manufacturers of Mono Hepatitis B Vaccine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Mono Hepatitis B Vaccine Typical Distributors
Table 107. Mono Hepatitis B Vaccine Typical Customers
List of Figures
Figure 1. Mono Hepatitis B Vaccine Picture
Figure 2. Global Mono Hepatitis B Vaccine Revenue Market Share by Type in 2021
Figure 3. Yeast Derived
Figure 4. CHO Derived
Figure 5. Global Mono Hepatitis B Vaccine Revenue Market Share by Application in 2021
Figure 6. Children
Figure 7. Adult
Figure 8. Global Mono Hepatitis B Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Mono Hepatitis B Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Mono Hepatitis B Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Mono Hepatitis B Vaccine Price (2017-2028) & (US$/Unit)
Figure 12. Global Mono Hepatitis B Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Mono Hepatitis B Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Mono Hepatitis B Vaccine Market Drivers
Figure 15. Mono Hepatitis B Vaccine Market Restraints
Figure 16. Mono Hepatitis B Vaccine Market Trends
Figure 17. Global Mono Hepatitis B Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Mono Hepatitis B Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Mono Hepatitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Mono Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Mono Hepatitis B Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Mono Hepatitis B Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Mono Hepatitis B Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Mono Hepatitis B Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Mono Hepatitis B Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Mono Hepatitis B Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Mono Hepatitis B Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Mono Hepatitis B Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Mono Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Mono Hepatitis B Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Mono Hepatitis B Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Mono Hepatitis B Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Mono Hepatitis B Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Mono Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Mono Hepatitis B Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Mono Hepatitis B Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Mono Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Mono Hepatitis B Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Mono Hepatitis B Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Mono Hepatitis B Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Mono Hepatitis B Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Mono Hepatitis B Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Mono Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Mono Hepatitis B Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Mono Hepatitis B Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Mono Hepatitis B Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Mono Hepatitis B Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Mono Hepatitis B Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Mono Hepatitis B Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Mono Hepatitis B Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Mono Hepatitis B Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Mono Hepatitis B Vaccine
Figure 77. Mono Hepatitis B Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のA型肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界の肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のA型肝炎及びB型肝炎用混合ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のA型＆B型肝炎ワクチン市場2022年：市場規模予測（～2028年）
  • 世界のA型肝炎ワクチン接種市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO20820 )"世界のB型肝炎ワクチン市場2022年：市場規模予測（～2028年）" (英文：Global Mono Hepatitis B Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。